Ads
related to: pharmaceutical industry
Search results
Data management highlights governance and quality - SiliconANGLE
SiliconANGLE· 5 days agoThrough its Intelligent Data Management Cloud, Informatica Inc. simplifies that process by...
Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks· 4 days agoIn the latest trading session, Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) closed at $146.97, marking a -1.82% move from the previous day. This move lagged the S&P 500's daily gain ...
3 Top Dividend Stocks to Maximize Your Retirement Income
Zacks· 1 day agoIn the past, investors going into retirement could invest in bonds and count on attractive yields to produce steady, reliable income streams to fund a predictable retirement. In addition to ...
Global Insulation Logistics Ltd
Data Center Dynamics· 2 days agoFor more than 10 years, Global Insulation Logistics has been right at the forefront of project delivery of insulated structures. This state of the art composite panel and door system far exceeds ...
Earth science tech CEO acquires $9,990 in company stock By Investing.com
Investing.com· 5 days agoIn a recent transaction, Giorgio R. Saumat, CEO of Earth Science Tech, Inc. (OTCMKTS:ETST), a...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoContinuous Bioprocessing Market to Be Worth $1.32 Billion by 2031 - Exclusive Report by Meticulous Research® PR Newswire REDDING, Calif., May 23, 2024 REDDING, Calif., May 23, 2024 /PRNewswire/ -- According to a new market research report titled
Vanda Pharma Rejects Future Pak's Sweetened Takeover Bid
Market Watch· 4 days agoThe board of Vanda Pharmaceuticals has rejected Future Pak's sweetened proposal for a takeover at $7.25 to $7.75 a share, saying the offer is still too low. The biopharmaceutical company's board ...
Jarvis: Private equity is bad for your health
The Columbian· 3 days agoThe bankruptcy of Steward Health has become the latest cautionary tale about private equity’s involvement in health care. Cerberus Capital Management’s purchase in 2010 of several Massachusetts-based ...
Cantor Fitzgerald sets price target on Skye Bioscience shares By Investing.com
Investing.com· 5 days agoOn Thursday, Cantor Fitzgerald began coverage on Skye Bioscience Inc. (NASDAQ:SKYE), assigning an...
Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know - Teva Pharmaceutical Indus...
Benzinga· 6 days agoLoading... Loading... Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus TEVA . And retail traders should know. We noticed this today when the positions ...